A detailed history of Ashton Thomas Securities, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 11,024 shares of NVO stock, worth $1.18 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
11,024
Previous 9,125 20.81%
Holding current value
$1.18 Million
Previous $1.28 Billion 2.37%
% of portfolio
0.26%
Previous 0.31%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$119.07 - $145.42 $226,113 - $276,152
1,899 Added 20.81%
11,024 $1.31 Billion
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $1.12 Million - $1.34 Million
9,125 New
9,125 $1.28 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $242B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ashton Thomas Securities, LLC Portfolio

Follow Ashton Thomas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Securities, LLC with notifications on news.